These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 30289804

  • 1. Impact of universal antiretroviral therapy for pregnant and postpartum women on antiretroviral therapy uptake and retention.
    Abrams EJ, Langwenya N, Gachuhi A, Zerbe A, Nuwagaba-Biribonwoha H, Mthethwa-Hleta S, Sahabo R, Lesosky M, Okello V, Myer L.
    AIDS; 2019 Jan 27; 33(1):45-54. PubMed ID: 30289804
    [Abstract] [Full Text] [Related]

  • 2. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
    Cunnama L, Abrams EJ, Myer L, Gachuhi A, Dlamini N, Hlophe T, Kikuvi J, Langwenya N, Mthethwa S, Mudonhi D, Nhlabatsi B, Nuwagaba-Biribonwoha H, Okello V, Sahabo R, Zerbe A, Sinanovic E.
    Trop Med Int Health; 2018 Sep 27; 23(9):950-959. PubMed ID: 29956426
    [Abstract] [Full Text] [Related]

  • 3. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
    van Lettow M, Bedell R, Mayuni I, Mateyu G, Landes M, Chan AK, van Schoor V, Beyene T, Harries AD, Chu S, Mganga A, van Oosterhout JJ.
    J Int AIDS Soc; 2014 Sep 27; 17(1):18994. PubMed ID: 25079437
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi.
    Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, Chirwa Z, Ng'ambi W, Bakali A, Phiri S, Myer L, Valeri F, Zwahlen M, Wandeler G, Keiser O.
    AIDS; 2014 Feb 20; 28(4):589-598. PubMed ID: 24468999
    [Abstract] [Full Text] [Related]

  • 6. Implementation of Antiretroviral Therapy for Life in Pregnant/Breastfeeding HIV+ Women (Option B+) Alongside Rollout and Changing Guidelines for ART Initiation in Rural Zimbabwe: The Lablite Project Experience.
    Ford D, Muzambi M, Nkhata MJ, Abongomera G, Joseph S, Ndlovu M, Mabugu T, Grundy C, Chan AK, Cataldo F, Kityo C, Seeley J, Katabira E, Gilks CF, Reid A, Hakim J, Gibb DM, Lablite Team.
    J Acquir Immune Defic Syndr; 2017 Apr 15; 74(5):508-516. PubMed ID: 27984555
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
    Erlwanger AS, Joseph J, Gotora T, Muzunze B, Orne-Gliemann J, Mukungunugwa S, Farley T, Mangwiro AZ.
    J Acquir Immune Defic Syndr; 2017 Jun 01; 75 Suppl 2():S198-S206. PubMed ID: 28498190
    [Abstract] [Full Text] [Related]

  • 11. Linkage to care, mobility and retention of HIV-positive postpartum women in antiretroviral therapy services in South Africa.
    Phillips TK, Clouse K, Zerbe A, Orrell C, Abrams EJ, Myer L.
    J Int AIDS Soc; 2018 Jul 01; 21 Suppl 4(Suppl Suppl 4):e25114. PubMed ID: 30027583
    [Abstract] [Full Text] [Related]

  • 12. Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda.
    Koss CA, Natureeba P, Kwarisiima D, Ogena M, Clark TD, Olwoch P, Cohan D, Okiring J, Charlebois ED, Kamya MR, Havlir DV.
    J Acquir Immune Defic Syndr; 2017 Mar 01; 74(3):279-284. PubMed ID: 27828878
    [Abstract] [Full Text] [Related]

  • 13. Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa.
    Myer L, Phillips TK.
    J Acquir Immune Defic Syndr; 2017 Jun 01; 75 Suppl 2():S115-S122. PubMed ID: 28498180
    [Abstract] [Full Text] [Related]

  • 14. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L, Namadingo H, Phiri M, Bobrow EA, Ahimbisibwe A, Berhan AY, Buono N, Moland KM, Tylleskär T.
    J Int AIDS Soc; 2016 Jun 01; 19(1):20919. PubMed ID: 27312984
    [Abstract] [Full Text] [Related]

  • 15. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
    Maskew M, Jamieson L, Mohomi G, Long L, Mongwenyana C, Nyoni C, Mokaba D, Fox MP, Sanne I, Rosen S.
    PLoS One; 2018 Jun 01; 13(8):e0201955. PubMed ID: 30161147
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Retention and viral suppression of newly diagnosed and known HIV positive pregnant women on Option B+ in Western Kenya.
    Akama E, Nimz A, Blat C, Moghadassi M, Oyaro P, Maloba M, Cohen CR, Bukusi EA, Abuogi LL.
    AIDS Care; 2019 Mar 01; 31(3):333-339. PubMed ID: 30261742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.